{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:14:33Z","timestamp":1784402073285,"version":"3.55.0"},"reference-count":5,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.3899\/jrheum.211126","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T13:20:18Z","timestamp":1639574418000},"page":"546-547","source":"Crossref","is-referenced-by-count":2,"title":["Baricitinib for Refractory Eosinophilic Fasciitis: Myth or Reality?"],"prefix":"10.3899","volume":"49","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-1575","authenticated-orcid":false,"given":"Jingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"2022062202350612000_49.5.546.1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200998"},{"key":"2022062202350612000_49.5.546.2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/1756-185X.13523","article-title":"Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma","volume":"22","author":"Low","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2022062202350612000_49.5.546.3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jdv.16948","article-title":"Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials","volume":"35","author":"Bieber","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062202350612000_49.5.546.4","first-page":"160","article-title":"In brief: new warnings for Janus kinase inhibitors","volume":"63","year":"2021","journal-title":"Medical Lett Drugs Ther"},{"key":"2022062202350612000_49.5.546.5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.55563\/clinexprheumatol\/e7ayu8","article-title":"JAK\/STAT pathway and nociceptive cytokine signaling in rheumatoid arthritis and psoriatic arthritis","volume":"39","author":"Crispino","year":"2021","journal-title":"Clin Exp Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.211126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T09:35:17Z","timestamp":1655890517000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.211126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":5,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,1]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.3899\/jrheum.211126"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.211126","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]}}}